ISSN: 1307-5888 | E-ISSN: 2757-7392 | Contact
Volume: 5 Issue: 4 Year: 2024
Copyright Transfer Form Author Contribution Form ICMJE COI Form
Submit an Article

Volume: 5 Issue: 3 - July 2024

Front Matter

1. Front Matter
Full Text PDF

Editorial

2. The evolution and revolution of artificial intelligence in hepatology: From current applications to future paradigms
Cem Simsek
DOI: 10.14744/hf.2024.2024.ed0001 PMCID: PMC11237248 Pages : 97-99
Full Text PDF

Research Articles

3. Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: A preliminary study
Kenan Moral, Berkay Simsek, Veysel Baran Tomar, Cihad Albayrak, Mustafa Ergin, Guner Kilic, Ali Karatas, Nergiz Ekmen, Murat Kekilli, Mehmet Ibis, Tarkan Karakan, Mehmet Cindoruk, Guldal Esendagli, Gulen Akyol
DOI: 10.14744/hf.2023.2023.0061 PMCID: PMC11237242 Pages : 100-105
Abstract Full Text PDF
4. The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in the Turkish population in HBV-related hepatocellular carcinoma
Duygu Bircan Kadioglu, Coskun Ozer Demirtas, Dilek Pirim, Feyza Dilber, Fatih Eren
DOI: 10.14744/hf.2023.2023.0054 PMCID: PMC11237244 Pages : 106-112
Abstract Full Text PDF
5. Comparison of triglyceride-glucose index and anthropometric obesity indices in predicting severe grades of hepatic steatosis in nonalcoholic fatty liver disease among non-diabetic obese individuals
Huseyin Karaaslan, Hasan Inan, Alper Tunga Turkmen, Ismail Altintas, Nida Uyar, Mehmet Ali Eren
DOI: 10.14744/hf.2023.2023.0049 PMCID: PMC11237241 Pages : 113-119
Abstract Full Text PDF
6. Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e antigen-negative patients
Cigdem Mermutluoglu, Omer Karasahin, Mustafa Kemal Celen
DOI: 10.14744/hf.2023.2023.0060 PMCID: PMC11237247 Pages : 120-125
Abstract Full Text PDF

Review Article

7. From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential
Sevginur AKDAS, Nuray YAZIHAN
DOI: 10.14744/hf.2023.2023.0042 PMCID: PMC11237240 Pages : 126-138
Abstract Full Text PDF
8. Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications
Nosheen Nasir, Iffat Khanum, Kiren Habib, Abdullah Wagley, Aleena Arshad, Atif Majeed
DOI: 10.14744/hf.2023.2023.0025 PMCID: PMC11237249 Pages : 139-149
Abstract Full Text PDF
9. Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma
Mete Ucdal, Ayse Burus, Basak Celtikci
DOI: 10.14744/hf.2023.2023.0028 PMCID: PMC11237245 Pages : 150-160
Abstract Full Text PDF

Brief Report

10. A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis
Hale Gokcan, Didem Kuru Oz, Emin Bodakci, Esra Tunc, Ramazan Idilman
DOI: 10.14744/hf.2024.2024.0020 PMCID: PMC11237243 Pages : 161-164
Abstract Full Text PDF

Letter to the Editor

11. Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
Ilkay Ergenc, Busra Gozaydınoglu, Caglayan Keklikkiran, Yusuf Yilmaz
DOI: 10.14744/hf.2024.2024.0007 PMCID: PMC11237246 Pages : 165-166
Full Text PDF